AASLD’s educational programming at DDW® is designed to provide a broad education on hot liver disease topics for general gastroenterologists, and deeper learning for hepatologists seeking information on the latest research and treatment advances, according to AASLD Secretary Kimberly A. Brown, MD, FAASLD.
The editors of AASLD’s flagships journals, HEPATOLOGY and Liver Transplantation, have organized a comprehensive update on important advances in chronic liver disease for this year’s Hepatology Update: The Year in Review. David Cohen, MD, PhD, FAASLD, editor in chief of HEPATOLOGY, and Paul Martin, MD, FAASLD, editor in chief of Liver Transplantation, will moderate.
An AASLD symposium on the final day of DDW® 2017 brought together experts from around the world to discuss pharmacological therapies, endoscopic therapies, interventional procedures
Alcoholic liver disease (ALD) is one of the leading causes of morbidity and mortality in the U.S. and worldwide. Three hepatologists discussed the management of
Studies have shown that success in losing weight is affected by how often patients see a health-care professional. Patients benefit from the doctor’s advice and
Patients who are hospitalized with cirrhosis are in trouble. They may have hepatic encephalopathy leading to impaired mentation and possible coma. They may have acute kidney injury that requires a liver transplant. They may have portal hypertension leading to ascites and spontaneous bacterial peritonitis. And they may have potentially fatal variceal bleeding.
Adequate nutrition is important for growth and meeting developmental milestones for all children. But for pediatric liver patients, overnutrition or undernutrition can have devastating effects.
The management of hepatocellular cancer (HCC) saw meaningful advances in 2016 with the introduction of two compounds, regorafenib and lenvatinib, for patients with advanced HCC.
Can viral hepatitis be eliminated? That’s the key question to be addressed Monday at the annual AGA Emmet B. Keeffe Symposium, Prevention of Viral Hepatitis Through Vaccination: Done or Just Getting Started?
Four experts will discuss the management for nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH) during Tuesday’s AASLD Clinical Symposium Identification and Management of Patients with NAFLD/NASH.
